CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:CellaVision AB (CEVI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013817
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis; software applications such as CellaVision remote review software and CellaVision remote review software Citrix ready; proficiency software; and accessories such as CellaVision light tower, HemaPrep and barcode label printer kit. Through its global partners, CellaVision distributes its products in Europe, the Middle East and Africa (EMEA), Asia Pacific and North America. CellaVision is headquartered in Lund, Sweden.

CellaVision AB (CEVI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CellaVision AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CellaVision AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CellaVision AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CellaVision AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
CellaVision AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CellaVision AB, Medical Equipment, Deal Details 10
Asset Purchase 10
CellaVision Acquires Technology Platform from Clear Lake Medical for USD1 Million 10
Partnerships 11
CellaVision Expands Distribution Agreement With Beckman Coulter 11
Cellavision Enters Into Distribution Agreement With Abbott 12
CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 13
Equity Offering 14
CellaVision Raises USD19 Million in Public Offering of Shares 14
CellaVision AB – Key Competitors 15
CellaVision AB – Key Employees 16
CellaVision AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Oct 25, 2017: CellaVision: Interim report January – September 2017 18
Jul 18, 2017: CellaVision: Strong second quarter with growth and increased profitability 20
Apr 07, 2017: CellaVision quantifies the outlook for the first quarter of 2017; Sales exceeding SEK 93 million in the first quarter of 2017 21
Feb 07, 2017: CellaVision: January-December 2016 22
Oct 27, 2016: CellaVision: Interim report January-September 2016 25
Jul 15, 2016: CellaVision: Interim Report January-June 2016 26
May 03, 2016: CellaVision: Interim report January-March 2016 28
Other Significant Developments 29
Jun 20, 2016: Sysmex Canada to Distribute CellaVision Systems 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
CellaVision AB, Medical Equipment, Key Facts, 2016 2
CellaVision AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CellaVision AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CellaVision AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CellaVision AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CellaVision AB, Deals By Market, 2011 to YTD 2017 8
CellaVision AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CellaVision Acquires Technology Platform from Clear Lake Medical for USD1 Million 10
CellaVision Expands Distribution Agreement With Beckman Coulter 11
Cellavision Enters Into Distribution Agreement With Abbott 12
CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions 13
CellaVision Raises USD19 Million in Public Offering of Shares 14
CellaVision AB, Key Competitors 15
CellaVision AB, Key Employees 16
CellaVision AB, Other Locations 17
CellaVision AB, Subsidiaries 17

★海外企業調査レポート[CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Investment Technology Group, Inc.
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aspial Corporation Ltd (A30):企業の財務・戦略的SWOT分析
    Aspial Corporation Ltd (A30) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Eneco Holding NV-エネルギー分野:企業M&A・提携分析
    Summary Eneco Holding N.V. (Eneco) is an integrated energy company. It produces, trades, transmits and supplies gas, electricity and heat. Eneco undertakes the sale, rental, installation, and maintenance of heating and hot water equipment; and maintenance of the electricity, gas and district heat ne …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Bureau Veritas SA:企業の戦略・SWOT・財務情報
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jack Henry & Associates Inc (JKHY):企業の財務・戦略的SWOT分析
    Jack Henry & Associates Inc (JKHY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China National Chemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, oil processing and refining products, basic chemicals, and rubber products. ChemChina also manufactures equi …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Tervita Corp:企業の戦略・SWOT・財務分析
    Tervita Corp - Strategy, SWOT and Corporate Finance Report Summary Tervita Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • VAALCO Energy, Inc. (EGY)-石油・ガス分野:企業M&A・提携分析
    Summary VAALCO Energy, Inc. (VAALCO) is an upstream energy company. It acquires, explores, develops and produces crude oil and natural gas. The company conducts exploration activities as operator in Gabon and as a non-operator in Equatorial Guinea, West Africa. VAALCO also owns minor in certain non- …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Center Parcs (Holdings 1) Limited:企業の戦略・SWOT・財務情報
    Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report Summary Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Recipharm AB:企業の戦略的SWOT分析
    Recipharm AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Worldpay Us Inc
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • AstraZeneca PLC:企業のM&A・事業提携・投資動向
    AstraZeneca PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AstraZeneca PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Trimedyne Inc (TMED):企業の戦略的SWOT分析
    Trimedyne Inc (TMED) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆